Treatment of experimental peri-implantitis using autogenous bone grafts and platelet-enriched fibrin glue in dogs.
OBJECTIVE
The purpose of this study was to evaluate the effects of autogenous bone grafts and platelet-enriched fibrin glue in the treatment of peri-implantitis.


METHODS
Thirty-six screw-type commercially pure titanium implants with rough acid-etched surfaces were inserted into 6 mongrel dogs 3 months after extraction of mandibular premolars. After 3 months of healing, peri-implantitis was induced by placing gauze and wire around the implants. Once peri-implantitis was created, surgical treatments involving a combination of autogenous bone grafts and platelet-enriched fibrin glue, autogenous bone grafts alone, or a conventional flap procedure only (control) were carried out. Six months later, biopsies of the implant sites were taken and prepared for ground sectioning and analysis.


RESULTS
The amount of reosseointegration was significantly higher in peri-implantitis defects treated with combined autogenous bone grafts and platelet-enriched fibrin glue as compared with the other 2 treatment procedures. A mean bone-to-implant contact of 50.1% was obtained in the peri-implantitis lesions treated with combined autogenous bone grafts and platelet-enriched fibrin glue. The corresponding values for the autogenous bone grafts and control groups were 19.3% and 6.5%, respectively.


CONCLUSIONS
The present study demonstrates that surgical treatment involving the combined use of autogenous bone grafts and platelet-enriched fibrin glue might effectively promote reosseointegration in lesions resulting from peri-implantitis.
You
Tae-Min
TM
Department of Oral & Maxillofacial Surgery, College of Dentistry, Yonsei University, Seoul and Wonju, South Korea.
Choi
Byung-Ho
BH
Zhu
Shi-Jiang
SJ
Jung
Jae-Hyung
JH
Lee
Seoung-Ho
SH
Huh
Jin-Young
JY
Lee
Hyun-Jung
HJ
Li
Jingxu
J
D016301:Alveolar Bone Loss / Q000601:surgery*; D000818:Animals; D001792:Blood Platelets; D016025:Bone Transplantation / Q000379:methods*; D015921:Dental Implants / Q000009:adverse effects*; D004285:Dogs; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use*; D007085:Ilium / Q000637:transplantation; D008336:Mandibular Diseases / Q000601:surgery; D014014:Tissue Adhesives / Q000627:therapeutic use*
D015921:Dental Implants; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives